• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • David Bishop, UK

    David Bishop, UK

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Mike Small, UK

    Mike Small, UK

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Jon Newsome, USA

    Jon Newsome, USA

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Len Johnrose, England

    Len Johnrose, England

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Mike Cels, Canada

    Mike Cels, Canada

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Ali Var, Turkey

    Ali Var, Turkey

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • John Dinon, Australia

    John Dinon, Australia

  • Purningam Jacob, India

    Purningam Jacob, India

  • Jason Goodman, USA

    Jason Goodman, USA

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Bob Simonds, USA

    Bob Simonds, USA

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login